Press-release for stocks

Prices are updated after-hours

crawled time : 14:00 source : Jaguarhealth.gcs-web.com

save search

Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
Published: 2023-03-02 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -90.06% | O: -2.34% H: 9.58% C: 0.0%
rare health

FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
Published: 2023-02-28 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -91.41% | O: -0.51% H: 1.52% C: -2.54%
fda rare designation drug disease health grants crofelemer microvillus

Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
Published: 2023-02-23 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -93.36% | O: 3.91% H: 1.5% C: -9.4%
fda drug patent health approved crofelemer

Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
Published: 2023-02-09 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -95.94% | O: 0.0% H: 4.29% C: 2.86%
health therapeutics

Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
Published: 2023-02-08 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -96.21% | O: -0.67% H: 1.35% C: -6.05%
health

Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
Published: 2023-02-01 (Crawled : 14:00) - jaguarhealth.gcs-web.com
PPRUF | News | $340.0 37.56% 1.5K

Consumer Non-Durables

| -44.68% | O: 1.76% H: 0.0% C: -1.72%
PPRUY | News | $33.79 -0.11% 360K

Manufacturing

| -45.91% | O: -0.86% H: 1.73% C: 1.08%
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -96.25% | O: 3.97% H: 1.7% C: -3.61%
health

Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
Published: 2023-01-30 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -11.04% | O: -0.18% H: 0.36% C: -3.53%
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -96.38% | O: -1.06% H: 1.94% C: 0.0%
fda health

Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
Published: 2023-01-26 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -96.57% | O: 1.41% H: 0.99% C: -10.34%
europe rare disease health

Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
Published: 2023-01-25 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -96.57% | O: 3.23% H: 2.93% C: -2.94%
health approved crofelemer milestone

Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Published: 2023-01-23 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -97.32% | O: -4.6% H: 1.49% C: -10.4%
health

Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
Published: 2023-01-20 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -97.32% | O: 8.87% H: 8.58% C: -8.03%
conference health

Sandra M. Swain, MD, FACP, FASCO Joins Jaguar Health's Scientific Advisory Board
Published: 2023-01-11 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -97.75% | O: 13.21% H: 7.02% C: 1.32%

Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar's Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Ps
Published: 2023-01-10 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -97.48% | O: 9.11% H: 12.02% C: 2.55%
diarrhea health medical therapeutics cancer

Jaguar Health Provides Updates on Presentation at the World Congress of Gastroenterology About Crofelemer for Pediatric Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDD) by Third-Party Investigator
Published: 2022-12-19 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -97.85% | O: 2.56% H: 1.66% C: -6.75%
health crofelemer presentation

Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea
Published: 2022-12-05 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology

| -98.16% | O: 1.46% H: 0.16% C: -6.97%
pharmaceuticals diarrhea health hiv

Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea
Published: 2022-11-21 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1704 1.43% 1.41% 34M

Health Technology